Caribou Biosciences, Inc.
CRBUNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $56.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.44$3.54
- Volume (live)
- -
- Avg. volume (3M)
- 4.13M
Caribou Biosciences (CRBU) Stock Price & Financial Analysis
Caribou Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.52 - $0.56 |
|---|---|
| 52-Week High | $3.54 |
| 52-Week Low | $0.44 |
| Open | $0.53 |
| Volume (last close) | 2.78M |
| Average Volume (3M) | 4.13M |
| Revenue (TTM) | 10.04M |
|---|---|
| Net Income (TTM) | -103.40M |
| Free Cash Flow (TTM) | -95.81M |
| EPS (TTM) | −$1.08 |
| Profit Margin | -1030.42% |
| Operating Margin | -1090.90% |
| Return on Equity (ROE) | -105.40% |
| Debt to Equity | 0.27 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 56.55M |
|---|---|
| Shares Outstanding | 100.99M |
| Price to Sales (P/S) | 5.64 |
| Price to Book (P/B) | 0.58 |
| EV/EBITDA | -0.55 |
| 50-Day MA | $1.25 |
|---|---|
| 200-Day MA | $1.68 |
| 1-Year Change | −77.60% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Caribou Biosciences at a Glance
As of the Oct 22, 2026 close, Caribou Biosciences (CRBU) has a market capitalization of $56.55M. The stock trades at 5.6× sales. Over the trailing twelve months it lost $103.40M on revenue of $10.04M and burned $95.81M of free cash flow. Revenue grew 10.0% year over year.
As of its latest reported balance sheet, it holds $26.19M in cash and securities against $26.66M of debt, a net debt position of $461.00K.
Caribou Biosciences does not currently pay a dividend.
The share price is down 77.6% over the past year. At $0.56 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.44 to $3.54, below its 200-day moving average of $1.68.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $3.75, 569.6% above the Oct 22, 2026 close.
Frequently Asked Questions About Caribou Biosciences
What is the current stock price for CRBU?
As of the Oct 22, 2026 close, CRBU stock trades at $0.56. The 52-week range is $0.44–$3.54, with a day range of $0.52–$0.56.
What is the P/E ratio for CRBU?
The P/E ratio (Price-to-Earnings) for CRBU is shown in the Key Statistics section. This valuation metric helps compare Caribou Biosciences, Inc. to industry peers.
Does CRBU pay dividends?
Caribou Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRBU?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for CRBU is Hold. The average 12-month price target is $3.75, a 569.6% upside from the Oct 22, 2026 close of $0.56.
What is the market cap of CRBU?
As of the Oct 22, 2026 close, Caribou Biosciences's market capitalization is $56.6M, classifying it as a micro-cap company. Caribou Biosciences operates in the Healthcare sector within the Biotechnology industry.